You just read:

Alliqua BioMedical Inc. and Adynxx, Inc. Announce Merger Agreement to Create NASDAQ-listed Clinical-Stage Pharmaceutical Company with a Focus on Pain and Inflammation

News provided by

Adynxx, Inc.

Oct 12, 2018, 07:00 ET